Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy-Reference-Cited by-同舟云学术

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy

Published:2006-03-10 Issue:5 Volume:58 Page:626-633
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Faltaos Demiana William,Hulot Jean Sebastian,Urien Saïk,Morel Veronique,Kaloshi Gentian,Fernandez Christine,Xuan khe Hoang,Leblond Veronique,Lechat Philippe

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0202-0.pdf

Reference27 articles.

1. Locatelli F, Zecca M, Messina C et al (2002) Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 16:2228–2237

2. Mantadakis E, Cole PD, Kamen BA (2005) High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use? Pharmacotherapy 25:748–755

3. Patte C, Michon J, Frappaz D et al (1994) Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults. Baillieres Clin Haematol 7:339–348

4. Shipp MA, Yeap BY, Harrington DP et al (1990) The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol 8:84–93

5. Aquerreta I, Aldaz A, Giraldez J et al (2004) Methotrexate pharmacokinetics and survival in osteosarcoma. Pediatr Blood Cancer 42:52–58

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies;European Journal of Clinical Pharmacology;2024-02-12

2. External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors;The Journal of Clinical Pharmacology;2024-01-11

3. A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy;British Journal of Clinical Pharmacology;2023-12-13

4. A new pharmacokinetic model of urinary methotrexate to assess adherence in rheumatoid arthritis;Biomedicine & Pharmacotherapy;2023-12

5. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review;European Journal of Clinical Pharmacology;2023-11-07